Valuation: 4DMedical Limited

Market Cap 2.37B 1.65B 1.44B 1.33B 1.23B 2.33B 157B 15.87B 6.23B 77.35B 6.18B 6.05B 266B P/E 2026 *
-12.5x
P/E 2027 * -63.1x
Enterprise Value 2.1B 1.46B 1.28B 1.18B 1.09B 2.07B 139B 14.1B 5.54B 68.7B 5.49B 5.37B 236B EV / Sales 2026 *
252x
EV / Sales 2027 * 96.1x
Free-Float
93.2%
Yield 2026 *
-
Yield 2027 * -
1 day-2.46%
1 week-6.82%
Current month-12.58%
1 month+9.09%
3 months-41.76%
6 months-14.29%
Current year+0.76%
1 week 3.85
Extreme 3.85
4.61
1 month 3.57
Extreme 3.57
5.08
Current year 2.95
Extreme 2.95
7.55
1 year 0.23
Extreme 0.23
7.55
3 years 0.22
Extreme 0.225
7.55
5 years 0.22
Extreme 0.225
7.55
10 years 0.22
Extreme 0.225
7.55
Manager TitleAgeSince
Chief Executive Officer - 2012-11-30
Director of Finance/CFO - 2026-01-01
Chief Tech/Sci/R&D Officer - 2023-03-31
Director TitleAgeSince
Director/Board Member - 2012-11-30
Chairman - 2023-11-01
Director/Board Member - 2017-09-30
Date Insider Type Main position Quantity % Market Cap.
06-18Buy

Chief Financial Officer

11,363 0.0019%
06-18Fiscal year

Chairman

-308,394 0.0518%
06-18Fiscal year

Chairman

308,394 0.0518%
Change 5-day change 1-year change 3-year change Capi.($)
-2.46%-6.82%+1,585.11%+435.14% 1.65B
+0.45%+0.69%+21.20%+1.50% 196B
-1.16%-4.51%-20.56%+19.96% 144B
+1.57%+0.57%-2.83%-16.25% 141B
-0.49%-0.82%-56.62%-14.64% 66.54B
+0.96%-2.29%+18.14%-0.25% 53.09B
+0.61%-1.09%-24.93%-30.81% 44.12B
+0.52%+2.75%+8.93%+13.34% 37.93B
-0.19%-0.75%+6.66%+42.84% 36.96B
0.00%-1.32%-13.88%-20.38% 29.43B
Average -0.02%-1.44%+152.12%+43.05% 75.05B
Weighted average by Cap. +0.26%-0.98%-0.44%+0.98%

Financials

2026 *2027 *
Net sales 8.34M 5.8M 5.07M 4.68M 4.32M 8.2M 553M 55.92M 21.96M 273M 21.78M 21.31M 937M 22.25M 15.48M 13.54M 12.49M 11.53M 21.89M 1.48B 149M 58.6M 727M 58.12M 56.85M 2.5B
Net income -177M -123M -108M -99.35M -91.76M -174M -11.74B -1.19B -466M -5.79B -462M -452M -19.89B -37.1M -25.8M -22.57M -20.82M -19.23M -36.48M -2.46B -249M -97.68M -1.21B -96.88M -94.77M -4.17B
Net Debt -264M -184M -161M -148M -137M -260M -17.54B -1.77B -696M -8.64B -691M -676M -29.71B -228M -159M -139M -128M -118M -225M -15.15B -1.53B -601M -7.46B -596M -583M -25.65B
Logo 4DMedical Limited
4DMedical Limited is a medical technology company that creates and deploys software-based cardiothoracic imaging technology integrating both algorithms and artificial intelligence. The Company's software platform delivers quantitative insights from routine clinical imaging to help clinicians assess lung function and cardiopulmonary disease. It provides thoracic imaging that enhances physician diagnoses and management of respiratory conditions. Its products include CT:VQ-Non-Contrast Ventilation-Perfusion, CAC-Coronary Artery Calcification, CT LVAS-Lung Ventilation Analysis, IQ-UIP-Early IPF Detection, LDAf-Functional Lung Density Analysis, LDAi-Lung Density Analysis – Inspiration, LTA-Lung Texture Analysis, PHA-Pulmonary Hypertension Assessment, XV LVAS-Lung Ventilation Analysis, and Companion Imaging. The CT:VQ is a non-contrast post-processing technology that transforms routine, chest computed tomographies (CTs) into quantitative, lobar ventilation (V) and perfusion (Q) maps.
Employees
124
Date Price Change Volume
26-07-10 A$3.960 -2.46% 6,874,373
26-07-09 A$4.060 -0.98% 4,362,023
26-07-08 A$4.100 -7.24% 10,320,058
26-07-07 A$4.420 +1.38% 6,011,896
26-07-06 A$4.360 +2.59% 5,895,131
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
BB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
3.960AUD
Average target price
4.967AUD
Spread / Average Target
+25.42%

Quarterly revenue - Rate of surprise